PortfoliosLab logoPortfoliosLab logo
ISIN
US44916K1060
CUSIP
44916K106
IPO Date
Jan 27, 2021

Highlights

Market Cap
$145.57M
Enterprise Value
$104.79M
EPS (TTM)
-$0.40
Total Revenue (TTM)
$15.33M
Gross Profit (TTM)
$7.85M
EBITDA (TTM)
-$35.19M
Year Range
$0.66 - $2.22
Target Price
$1.60
ROA (TTM)
-57.64%
ROE (TTM)
-101.22%

Share Price Chart


Loading charts...

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Hyperfine, Inc.

Often compared with HYPR:
HYPR vs. QQQ

Performance

HYPR Performance Chart

Hyperfine, Inc. (HYPR) is up 52.2% since the beginning of the year. At $1 per share, HYPR is trading 32.9% below its 52-week high of $2. Investors who bought $1,000 worth of HYPR shares 5 years ago would now be looking at an investment worth $152.


Loading charts...

S&P 500 Index

Returns By Period

Hyperfine, Inc. (HYPR) has returned 52.15% so far this year and 101.46% over the past 12 months.


Hyperfine, Inc.

1D
-0.67%
1M
-17.68%
YTD
52.15%
6M
58.59%
1Y
101.46%
3Y*
-2.55%
5Y*
-31.41%
10Y*

Benchmark (S&P 500 Index)

1D
-0.74%
1M
4.90%
YTD
10.35%
6M
10.28%
1Y
26.52%
3Y*
20.83%
5Y*
12.30%
10Y*
13.66%
*Multi-year figures are annualized to reflect compound growth (CAGR)

HYPR Monthly Returns History

Based on dividend-adjusted daily data since Jan 27, 2021, HYPR's average daily return is +0.03%, while the average monthly return is -0.70%.

Historically, 45% of months were positive and 55% were negative. The best month was Feb 2023 with a return of +67.3%, while the worst month was Jul 2022 at -45.7%. The longest winning streak lasted 4 consecutive months, and the longest losing streak was 8 months.

On a daily basis, HYPR closed higher 44% of trading days. The best single day was Dec 12, 2022 with a return of +53.8%, while the worst single day was Oct 16, 2025 at -35.5%.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
202614.37%-4.46%0.93%53.70%-6.02%-4.49%52.15%
202525.00%-11.82%-26.15%1.21%-16.90%19.44%47.30%16.98%16.94%-22.76%-4.46%-8.48%11.28%
2024-4.46%7.48%-13.04%-19.00%3.21%1.67%37.65%-13.68%6.93%-9.39%3.21%-12.87%-21.43%
202314.60%67.26%-10.56%-2.08%16.31%31.10%35.35%-29.21%-0.49%-39.02%2.40%-12.50%33.33%
2022-39.59%-17.81%-1.67%-2.26%-16.47%-22.84%-45.74%10.74%-39.55%12.35%-12.09%5.00%-88.41%
20210.90%2.57%-3.47%-0.00%-1.20%-0.30%0.41%0.20%-0.10%0.81%0.00%-27.35%-27.57%

Benchmark Metrics

Hyperfine, Inc. has an annualized alpha of -10.87%, beta of 1.27, and R2 of 0.05 versus S&P 500 Index. Calculated based on daily prices since January 28, 2021.

  • This stock participated in 208.72% of S&P 500 Index downside but only 44.39% of its upside - more exposed to losses than it benefited from rallies.
  • R2 of 0.05 means this stock moves largely independently of S&P 500 Index - capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.

Alpha
-10.87%
Beta
1.27
0.05
Upside Capture
44.39%
Downside Capture
208.72%

Return for Risk

Risk / Return Rank

HYPR ranks 72 for risk / return — better than 72% of stocks on our site. You're getting solid returns for the risk taken. A good sign, especially for investors who want growth without excessive volatility.


HYPR Risk / Return Rank: 7272
Overall Rank
HYPR Sharpe Ratio Rank: 7474
Sharpe Ratio Rank
HYPR Sortino Ratio Rank: 7474
Sortino Ratio Rank
HYPR Omega Ratio Rank: 7474
Omega Ratio Rank
HYPR Calmar Ratio Rank: 7171
Calmar Ratio Rank
HYPR Martin Ratio Rank: 6565
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

Return / Risk — by metrics

The table below present risk-adjusted performance metrics for Hyperfine, Inc. (HYPR) and compare them to S&P 500 Index.


HYPRBenchmarkDifference

Sharpe ratio

Return per unit of total volatility

1.08

2.24

-1.16

Sortino ratio

Return per unit of downside risk

1.96

3.07

-1.11

Omega ratio

Gain probability vs. loss probability

1.25

1.41

-0.15

Calmar ratio

Return relative to maximum drawdown

1.73

2.93

-1.20

Martin ratio

Return relative to average drawdown

2.74

13.52

-10.78

Dividends

Dividend History


Hyperfine, Inc. doesn't pay dividends

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.


Loading charts...

Worst Drawdowns

The table below displays the maximum drawdowns of the Hyperfine, Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Hyperfine, Inc. was 95.01%, occurring on May 23, 2025. The portfolio has not yet recovered.

The current Hyperfine, Inc. drawdown is 86.36%.


Related event

Drawdown

Fall

Recovery

Underwater

2025 selloff2025
-95.01%May 2025
3y 5mo
4y 5moDec 2021 - now
2021 correction2021
-10.54%Jun 2021
4mo 6d6mo 2d
10mo 8dFeb 2021 - Dec 2021
2021 pullback2021
-0.88%Jan 2021
0s4d
4dJan 2021 - Feb 2021
2021 pullback2021
-0.83%Feb 2021
0s5d
5dFeb 2021 - Feb 2021
2021 pullback2021
-0.29%Feb 2021
0s1d
1dFeb 2021 - Feb 2021

Drawdown Indicators


HYPRBenchmarkDifference

Max Drawdown

Largest peak-to-trough decline

-95.01%

-56.78%

-38.23%

Max Drawdown (1Y)

Largest decline over 1 year

-59.09%

-9.10%

-49.99%

Max Drawdown (3Y)

Largest decline over 3 years

-82.81%

-18.90%

-63.91%

Max Drawdown (5Y)

Largest decline over 5 years

-95.01%

-25.43%

-69.58%

Max Drawdown (10Y)

Largest decline over 10 years

-33.92%

Current Drawdown

Current decline from peak

-86.36%

-0.74%

-85.62%

Average Drawdown

Average peak-to-trough decline

-72.76%

-10.72%

-62.04%

Ulcer Index

Depth and duration of drawdowns from previous peaks

37.13%

1.97%

+35.16%

Volatility

Volatility Chart

The chart below shows the rolling one-month volatility.


Loading charts...

Financials

Financial Performance

The chart below illustrates the trends in the financial health of Hyperfine, Inc. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.


Annual
Quarterly

0.0

Valuation

The Valuation section provides an overview of how Hyperfine, Inc. is priced in the market compared to other companies in the Medical Devices industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.


PS Ratio

This chart shows the Price-to-Sales (P/S) ratio for HYPR relative to other companies in the Medical Devices industry. Currently, HYPR has a P/S ratio of 8.5. This P/S ratio is high relative to other companies in the industry. It could mean the stock is overvalued, or that investors expect strong future growth and profitability.

PB Ratio

The chart illustrates the Price-to-Book (P/B) ratio for HYPR in comparison with other companies in the Medical Devices industry. Currently, HYPR has a P/B value of 4.2. This P/B ratio is in line with the industry average, suggesting the stock is valued fairly in relation to its book value.

Income Statement



TTM
Revenue

Total Revenue

Cost Of Revenue

Gross Profit

Operating Expenses

Selling, General & Admin Expenses

R&D Expenses

Depreciation And Amortization

Total Operating Expenses

Income

Income Before Tax

Operating Income

EBITDA

EBIT

Earnings From Continuing Operations

Net Income

Income Tax Expense

Other Non-Operating Income (Expenses)

Extraordinary Items

Discontinued Operations

Effect Of Accounting Charges

Non Recurring

Minority Interest

Other Items

Interest Income

Interest Expense

Net Interest Income

Values in undefined except per share items
Portfolio Analyzer

Build a portfolio with HYPR

Add Hyperfine, Inc. to a portfolio and analyze allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Analyzer with HYPR